Elevation Oncology Inc (ELEV)

01:05 AM

Elevation Oncology Explores Strategic Alternatives - marketscreener.com

01:05 AM

07:30 AM

Elevation Oncology Advances Novel HER3 ADC Program While Securing Cash Runway Through 2026 - Stock Titan

07:30 AM

07:03 AM

Elevation Oncology, Inc. SEC 10-Q Report - TradingView

07:03 AM

May 14, 2025

Allogene's Q1 Earnings In Line With Estimates, Sales Nil - Barchart.com

May 14, 2025

May 09, 2025

Insmed's Q1 Loss Wider Than Expected, Sales Match Estimates - Yahoo Finance

May 09, 2025

May 09, 2025

Iovance's Q1 Earnings & Sales Miss, Stock Slides 39% On '25 View Cut - Barchart.com

May 09, 2025

May 09, 2025

Iovance's Q1 Earnings & Sales Miss, Stock Slides 39% on '25 View Cut - Yahoo Finance

May 09, 2025

May 08, 2025

Elevation Oncology, Inc. (NASDAQ:ELEV) Receives Average Recommendation of “Hold” from Brokerages - Defense World

May 08, 2025

May 07, 2025

Perrigo Q1 Earnings Beat Estimates, Revenues Decline Y/Y - The Globe and Mail

May 07, 2025

May 07, 2025

JAZZ Misses Q1 Earnings & Sales Estimates, Cuts '25 EPS Outlook - Zacks Investment Research

May 07, 2025

May 06, 2025

JPMorgan Chase & Co. Purchases 119,041 Shares of Elevation Oncology, Inc. (NASDAQ:ELEV) - Defense World

May 06, 2025

May 02, 2025

Geode Capital Management LLC Grows Stock Holdings in Elevation Oncology, Inc. (NASDAQ:ELEV) - Defense World

May 02, 2025

May 01, 2025

Renaissance Technologies LLC Sells 182,673 Shares of Elevation Oncology, Inc. (NASDAQ:ELEV) - Defense World

May 01, 2025

Apr 29, 2025

William Blair Reaffirms Their Buy Rating on Elevation Oncology (ELEV) - The Globe and Mail

Apr 29, 2025

Apr 29, 2025

Elevation Oncology Inc Inc. (ELEV) Price Performance: The Role of Share Buybacks and Stock Splits - investchronicle.com

Apr 29, 2025

Apr 28, 2025

Layoff Tracker: Ono Cuts 83 Employees in Massachusetts - BioSpace

Apr 28, 2025

Apr 28, 2025

Elevation Oncology Inc (ELEV)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX

Apr 28, 2025

Apr 28, 2025

Elevation Oncology Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView

Apr 28, 2025

Apr 25, 2025

Elevation Oncology reveals promising ADC data for solid tumors - Investing.com

Apr 25, 2025

Apr 25, 2025

Elevation Oncology reveals promising ADC data for solid tumors By Investing.com - Investing.com India

Apr 25, 2025

Apr 25, 2025

Breakthrough Cancer Drug EO-1022 Outperforms Existing HER3 Therapies in Stability and Anti-Tumor Activity - Stock Titan

Apr 25, 2025

Apr 24, 2025

Adversity is less terrifying than hope: Elevation Oncology Inc (ELEV) - Sete News

Apr 24, 2025

Apr 24, 2025

Elevation Oncology (ELEV) to Release Quarterly Earnings on Thursday - Defense World

Apr 24, 2025

Apr 23, 2025

Market Recap Check: Elevation Oncology Inc (ELEV)’s Negative Finish at 0.37, Up/Down -1.61 - DWinneX

Apr 23, 2025

Apr 22, 2025

Potential Price Increase for Elevation Oncology Inc (ELEV) After Recent Insider Activity - knoxdaily.com

Apr 22, 2025

Apr 22, 2025

Are Elevation Oncology Inc’shares a good deal? - uspostnews.com

Apr 22, 2025

Apr 21, 2025

Elevation Oncology Inc (ELEV): What Makes The Stock Good? - Marketing Sentinel

Apr 21, 2025

Apr 18, 2025

GSK prepares to relaunch Blenrep; Activists challenge another ‘zombie’ biotech - BioPharma Dive

Apr 18, 2025

Apr 18, 2025

Elevation mulls strategic alternatives, including closure, amid activist pressure - PharmaLive

Apr 18, 2025

Apr 18, 2025

Elevation Mulls Strategic Alternatives, Including Closure, Amid Activist Pressure - BioSpace

Apr 18, 2025

Apr 17, 2025

Finance Watch: Investors Push ESSA Pharma, Elevation Oncology To Wind Down - insights.citeline.com

Apr 17, 2025

Apr 16, 2025

Analysts Set Elevation Oncology, Inc. (NASDAQ:ELEV) PT at $3.39 - Defense World

Apr 16, 2025

Apr 14, 2025

Rare NRG1 Fusion Market to Reach New Heights in Growth by 2034, - openPR.com

Apr 14, 2025

Apr 11, 2025

Fierce Biotech Layoff Tracker 2025: Pfizer sells site, cuts staff; Opthea reduces workforce by 65% - Fierce Biotech

Apr 11, 2025

Apr 08, 2025

Trading Day Review: Elevation Oncology Inc (ELEV) Loses Momentum, Closing at 0.25 - DWinneX

Apr 08, 2025

Apr 04, 2025

Elevation Oncology opts for early term loan repayment By Investing.com - Investing.com South Africa

Apr 04, 2025

Apr 04, 2025

Elevation Oncology opts for early term loan repayment - Investing.com

Apr 04, 2025

Apr 04, 2025

Elevation Oncology IncTo Prepay Term Loan Under Loan & Security Agreement Dated July 27, 2022SEC Filing - MarketScreener

Apr 04, 2025

Apr 03, 2025

Elevation Oncology stock hits 52-week low at $0.24 By Investing.com - Investing.com Canada

Apr 03, 2025

Apr 02, 2025

Virtu Financial LLC Takes $36,000 Position in Elevation Oncology, Inc. (NASDAQ:ELEV) - Defense World

Apr 02, 2025

Apr 01, 2025

Elevation Oncology’s Chief Medical Officer Steps Down - TipRanks

Apr 01, 2025

Apr 01, 2025

What is Elevation Oncology Inc (ELEV) Stock Return on Shareholders’ Capital? - Sete News

Apr 01, 2025

Mar 31, 2025

A closer look at Elevation Oncology Inc (ELEV)’s stock price trends - uspostnews.com

Mar 31, 2025

Mar 25, 2025

Elevation Oncology to Present Preclinical Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025 - Longview News-Journal

Mar 25, 2025

Mar 25, 2025

Breakthrough Cancer Drug Shows Promise: First Look at EO-1022 Data for Breast and Lung Cancer - Stock Titan

Mar 25, 2025

Mar 25, 2025

Elevation Oncology (NASDAQ:ELEV) Given “Equal Weight” Rating at Stephens - Defense World

Mar 25, 2025

Mar 24, 2025

Analysts Set Expectations for ELEV FY2029 Earnings - Defense World

Mar 24, 2025

Mar 24, 2025

Elevation Oncology (NASDAQ:ELEV) Cut to “Neutral” at Piper Sandler - The AM Reporter

Mar 24, 2025

Mar 23, 2025

Massachusetts-Based Elevation Oncology Cuts 70% of Workforce After Drug Setback - NewsBreak: Local News & Alerts

Mar 23, 2025